ANTILEUKEMIC ACTIVITY OF THE TYROSINE KINASE INHIBITOR BVT II plus /- CYTARABINE OR DAUNORUBICIN IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Eriksson, A. [1 ]
Hassan, S. Bashir [1 ]
Hoglund, M. [1 ]
Larsson, R. [1 ]
Lindhagen, E. [1 ]
Aleskog, A. [1 ]
Fohlenhag, K. [2 ]
Jensen, A. Jenmalm [2 ]
Lehmann, F. [2 ]
Lothgren, A. [2 ]
Parrow, V. [2 ]
机构：
[1] Uppsala Univ, Uppsala, Sweden
[2] Biovitrum AB, Discovery Res, Stockholm, Sweden
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0290
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [1] Significant preclinical antileukemic activity of the tyrosine kinase inhibitor BVT I in acute myeloid leukemia
    Eriksson, S.
    Hassan, S.
    Hoglund, M.
    Larsson, R.
    Lindhagen, E.
    Aleskog, A.
    Lothgren, A.
    Fohlenhag, K.
    Jensen, A. Jenmalm
    Parrow, V.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 114 - 115
  • [2] A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia
    Masaoka, T
    Ogawa, M
    Yamada, K
    Kimura, K
    Ohashi, Y
    [J]. SEMINARS IN HEMATOLOGY, 1996, 33 (04) : 12 - 17
  • [3] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
    Murphy, Tracy
    Yee, Karen W. L.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
  • [4] Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
    Ikezoe, Takayuki
    Ando, Kiyoshi
    Onozawa, Masahiro
    Yamane, Takahisa
    Hosono, Naoko
    Morita, Yasuyoshi
    Kiguchi, Toru
    Iwasaki, Hiromi
    Miyamoto, Toshihiro
    Matsubara, Keisuke
    Sugimoto, Saori
    Miyazaki, Yasushi
    Kizaki, Masahiro
    Akashi, Koichi
    [J]. CANCER SCIENCE, 2022, 113 (12) : 4258 - 4266
  • [5] Mitoxantrone plus cytarabine versus daunorubicin plus cytarabine as induction therapy for previously untreated adult patients with acute myeloid leukemia
    Nikanfar, Alireza
    Asvadi, Iraj
    Vaez, Jalil
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2007, 23 (06) : 909 - 912
  • [6] The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia
    Eriksson, A.
    Hermanson, M.
    Wickstrom, M.
    Lindhagen, E.
    Ekholm, C.
    Jensen, A. Jenmalm
    Lothgren, A.
    Lehmann, F.
    Larsson, R.
    Parrow, V.
    Hoglund, M.
    [J]. BLOOD CANCER JOURNAL, 2012, 2 : e81 - e81
  • [7] The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia
    A Eriksson
    M Hermanson
    M Wickström
    E Lindhagen
    C Ekholm
    A Jenmalm Jensen
    A Löthgren
    F Lehmann
    R Larsson
    V Parrow
    M Höglund
    [J]. Blood Cancer Journal, 2012, 2 : e81 - e81
  • [8] Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia
    Hu, Shuiying
    Niu, Hongmei
    Inaba, Hiroto
    Orwick, Shelley
    Rose, Charles
    Panetta, John C.
    Yang, Shengping
    Pounds, Stanley
    Fan, Yiping
    Calabrese, Christopher
    Rehg, Jerold E.
    Campana, Dario
    Rubnitz, Jeffrey E.
    Baker, Sharyn D.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (11) : 893 - 905
  • [9] Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
    Roellig, C.
    Kramer, M.
    Gabrecht, M.
    Haenel, M.
    Herbst, R.
    Kaiser, U.
    Schmitz, N.
    Kullmer, J.
    Fetscher, S.
    Link, H.
    Mantoyani-Loeffler, L.
    Kruempelmann, U.
    Neuhaus, T.
    Heits, F.
    Einsele, H.
    Ritter, B.
    Bornhaeuser, M.
    Schetelig, J.
    Thiede, C.
    Mohr, B.
    Schaich, M.
    Platzbecker, U.
    Schaefer-Eckart, K.
    Kraemer, A.
    Berdel, W. E.
    Serve, H.
    Ehninger, G.
    Schuler, U. S.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (04) : 973 - 978
  • [10] Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia
    Meunier, Godelieve
    Birsen, Rudy
    Cazelles, Clarisse
    Belhadj, Maya
    Cantero-Aguilar, Lilia
    Kosmider, Olivier
    Fontenay, Michaela
    Azar, Nabih
    Mayeux, Patrick
    Chapuis, Nicolas
    Tamburini, Jerome
    Bouscary, Didier
    [J]. ONCOGENESIS, 2020, 9 (10)
12345